日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

开发用于临床规模生产原代人NK细胞和α逆转录病毒嵌合抗原受体工程的自动化分离、扩增和质量控制方案

Oberschmidt Olaf, Morgan Michael, Huppert Volker, Kessler Joerg, Gardlowski Tanja, Matthies Nadine, Aleksandrova Krasimira, Arseniev Lubomir, Schambach Axel, Koehl Ulrike, Kloess Stephan

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

三体介导IL-2激活的供体自然杀伤(NK)细胞抗白血病反应性增强,并损害其表达CD33的NK细胞亚群的活力。

Kloess, Stephan; Ede Valverde da Silva, Alessa; Oberschmidt, Olaf; Gardlowski, Tanja; Matthies, Nadine; Vyas, Maulik; Arseniev, Lubomir; Heuser, Michael; Pogge von Strandmann, Elke; Köhl, Ulrike

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment

重定向的人类嵌合抗原受体自然杀伤细胞作为一种“现成的免疫疗法”用于改善癌症治疗

Oberschmidt, Olaf; Kloess, Stephan; Koehl, Ulrike